Analysis of FDA Drug GMP Warning Letters for FYs 2020 and 2021

By Barbara W. Unger

In this report you will see:

  • In-depth analysis of FDA Warning Letters issued in FY2020 and FY2021
  • FDA enforcement trends as indicated by this analysis
  • How these trends compare to enforcement trends since FY2013